Key result
Diagnostic and therapeutic approaches to canine myxomatous mitral valve disease are evolving alongside the latest technological advancements in the field.
This article reviews the current diagnostic and therapeutic approaches to canine myxomatous mitral valve disease, including recent technological advancements.
Answers are grounded in this paper and cite their sources.
Clinicians should track emerging technologies for canine MMVD; this review leaves open the need for prospective validation studies.
The most common heart disease that affects dogs is myxomatous mitral valve disease. In this article, we review the current diagnostic and therapeutic approaches to this disease, and we also present some of the latest technological advancements in this field.
No takes yet. Share an insight, caveat, or question.
Menciotti et al. (2017) studied this question. Diagnostic and therapeutic approaches to canine myxomatous mitral valve disease are evolving alongside the latest technological advancements in the field.
Synapse has enriched 10 related papers. Consider them for comparative context: